These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8859003)

  • 41. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
    Ritter JK; Schmidt CJ; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1984 May; 229(2):487-92. PubMed ID: 6201607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
    Hamamura T; Akiyama K; Akimoto K; Kashihara K; Okumura K; Ujike H; Otsuki S
    Brain Res; 1991 Apr; 546(1):40-6. PubMed ID: 1677305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum.
    Jayanthi S; McCoy MT; Beauvais G; Ladenheim B; Gilmore K; Wood W; Becker K; Cadet JL
    PLoS One; 2009 Jun; 4(6):e6092. PubMed ID: 19564919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex.
    Stephans SE; Yamamoto BY
    Brain Res; 1995 Nov; 700(1-2):99-106. PubMed ID: 8624733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Miyoshi A; Koumoto A; Tanaka K; Nishiyama N; Morita Y; Takemura M
    Pharmacol Biochem Behav; 2010 Jan; 94(3):464-70. PubMed ID: 19895842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):401-6. PubMed ID: 7195265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.
    Morisset S; Pilon C; Tardivel-Lacombe J; Weinstein D; Rostene W; Betancur C; Sokoloff P; Schwartz JC; Arrang JM
    J Pharmacol Exp Ther; 2002 Feb; 300(2):621-8. PubMed ID: 11805225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region.
    Hassanlou AA; Jamali S; RayatSanati K; Mousavi Z; Haghparast A
    Brain Res Bull; 2021 Jul; 172():43-51. PubMed ID: 33862125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of dopamine D1 receptors in striatal fos protein induction associated with methamphetamine behavioral sensitization in rats.
    Yoshida H; Ohno M; Watanabe S
    Brain Res Bull; 1995; 38(4):393-7. PubMed ID: 8535862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
    Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
    J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats.
    Chen PC; Chen JC
    Neuropsychopharmacology; 2005 Mar; 30(3):538-49. PubMed ID: 15536496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.
    Park SW; Shen X; Tien LT; Roman R; Ma T
    J Biomed Sci; 2011 Nov; 18(1):83. PubMed ID: 22074218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine.
    Yamada S; Kojima H; Yokoo H; Tsutsumi T; Takamuki K; Anraku S; Nishi S; Inanaga K
    Biol Psychiatry; 1988 Aug; 24(4):399-408. PubMed ID: 3408757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ["Methamphetamine-stereotypies" and brain dopamine levels of rats treated with single or repeated doses of alpha-methyl-para-tyrosine (author's transl)].
    Kobayashi M; Wakamatsu Y; Shinohara M; Teraoka Y; Koshikawa N
    Nihon Yakurigaku Zasshi; 1977 Sep; 73(6):695-701. PubMed ID: 562821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1991 Nov; 205(1):43-7. PubMed ID: 1811995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of N-ethylmaleimide on dopamine release in the rat striatum after repeated treatment with methamphetamine.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1994 May; 257(3):243-8. PubMed ID: 7916300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K; Sato M; Otsuki S
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptide S attenuates methamphetamine-induced stereotyped behavior in rats.
    Li X; Jiang F; Yao K; Yang L; Gao X; Chen H; Wei X; Wu N; Zhou R; Yuan W; Zhang S
    Biochem Biophys Res Commun; 2020 Jun; 527(1):98-103. PubMed ID: 32446398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice.
    Tulloch I; Ghazaryan N; Mexhitaj I; Ordonez D; Angulo JA
    Brain Res; 2011 Jul; 1399():33-9. PubMed ID: 21652034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of dopamine intracerebrally injected by the Valzelli method on methamphetamine-stereotypy and hypermotility].
    Nomura Y; Ashikari S; Naganuma K; Sakuma K; Watanabe M; Kobayashi M
    Yakubutsu Seishin Kodo; 1982 Jul; 2(1):25-37. PubMed ID: 6892350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.